Back to top

Image: Bigstock

Earnings Estimates Moving Higher for TriNet (TNET): Time to Buy?

Read MoreHide Full Article

TriNet Group, Inc. (TNET - Free Report) is a leading provider of human resources solutions for small to mid-sized businesses that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on TNET’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that TriNet could be a solid choice for investors.

Current Quarter Estimates for TNET

In the past 30 days, one estimate has gone higher for TriNet while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from 46 cents a share 30 days ago, to 64 cents today, a move of 39.1%.

Current Year Estimates for TNET

Meanwhile, TriNet’s current year figures are also looking quite promising, with four estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from $1.98 per share 30 days ago to $2.59 per share today, an increase of 30.8%.

Bottom Line

The stock has also started to move higher lately, adding 11.1% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So, investors may want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank stocks here.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


TriNet Group, Inc. (TNET) - free report >>

Published in